T-group (topology)
243.5.1 Amine oxidase N-terminal region
Ligands and drugs
963
Member domains
462
with ligand contacts (≤ 4 Å)
48.0% of members
313
with DrugDomain annotations
32.5% of members
143
with a DrugBank compound
14.8% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 243.5.1 belongs to X-group 243 Cystatin-like, which binds 8.3 ligand superclasses per 20 proteins, broader than 62% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 51 |
| DB02178 | HY1 | Phenylacetaldehyde | 24 |
| DB02464 | ABN | Benzylamine | 6 |
| DB04325 | PEA | Phenethylamine | 4 |
| DB03843 | FOR | Formaldehyde | 3 |
| DB00594 | — | Amiloride | 2 |
| DB00738 | PNT | Pentamidine | 2 |
| DB00780 | — | — | 2 |
| DB01275 | — | Hydralazine | 2 |
| DB01373 | — | — | 2 |
| DB02192 | PEL | Phenylethyl alcohol | 2 |
| DB03608 | BRN | Diminazene | 2 |
| DB04334 | — | — | 2 |
| DB05383 | — | Pimagedine | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAmetal | SODIUM ION | 148 |
| CAmetal | CALCIUM ION | 78 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 33 |
| HY1 | PHENYLACETALDEHYDE | 24 |
| PEA | 2-PHENYLETHYLAMINE | 16 |
| CL | CHLORIDE ION | 12 |
| XE | XENON | 11 |
| CUmetal | COPPER (II) ION | 9 |
| Kmetal | POTASSIUM ION | 9 |
| IOD | IODIDE ION | 8 |
| BR | BROMIDE ION | 7 |
| ABN | BENZYLAMINE | 6 |
| MNmetal | MANGANESE (II) ION | 6 |
| NEH | ETHANAMINE | 6 |
| R4A | BIS[1H,1'H-2,2'-BIPYRIDINATO(2-)-KAPPA~2~N~1~,N~1'~]{3-[4-(1,10-DIHYDRO-1,10-PHENANTHROLIN-4-YL-KAPPA~2~N~1~,N~10~)BUTOXY]-N,N-DIMETHYLANILINATO(2-)}RUTHENIUM | 5 |
| JW7 | 5-(cyclohexylamino)-2-phenyl-6-(1H-1,2,4-triazol-5-yl)-3(2H)-pyridazinone | 4 |
| JWF | 5-[4-(4-methylpiperazin-1-yl)phenylamino]-2-(4-chlorophenyl)-6-(1H-1,2,4-triazol-5-yl)-3(2H)-pyridazinone | 4 |
| WF8 | 5-isopropylamino-2-phenyl-6-(1H-1,2,4-triazol-5-yl)-3(2H)-pyridazinone | 4 |
| FOR | FORMYL GROUP | 3 |
| TLA | L(+)-TARTARIC ACID | 3 |